Clinical Trial

Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer

Study acronym: GC/GEJC
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is a single-center, retrospective cohort study. The purpose is to evaluate different perioperative treatment options on the efficacy and survival prognosis of locally advanced GC/GEJC, clarify whether the tumor regression grade can influence survival of patients using neoadjuvant therapy. Moreover, we aim to explore the clinical and pathological characteristics that will affect the long-term survival benefit of patients who underwent perioperative treatment.
Trial Details
NCT Number NCT07429318
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Enrollment 300 participants
Start Date 2026-01-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-24